Home › Funds › Hamilton Capital, LLC › ABT

Hamilton Capital, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Hamilton Capital, LLC reported holding 47,808 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 0.27% of its reported portfolio and ranking #20 among its reported holdings. Hamilton Capital, LLC has disclosed ABT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)47.81K sh
Reported value held$4.72M
Portfolio Weight0.27%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Hamilton Capital, LLC's ABT position evolved

Hamilton Capital, LLC first disclosed a stake in ABT in Q3 2023 at 11,643 shares (US$1.1M). The position peaked in Q3 2026 at 47,808 shares, worth US$4.7M. Across 12 filings, Hamilton Capital, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 47,808 shares valued at US$4.7M — a reduction of -666 shares quarter over quarter.. Notable position changes include a 47% trim in Q2 2025 (shares fell 1% over the following quarter), a 831% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.64K $1.13M New
Q4 2023 13.53K $1.49M Add
Q1 2024 13.73K $1.56M Add
Q2 2024 13.24K $1.38M Reduce
Q3 2024 12.00K $1.36M Reduce
Q4 2024 12.31K $1.39M Add
Q1 2025 11.61K $1.54M Reduce
Q2 2025 6.14K $835.70K Reduce
Q4 2025 6.84K $857.23K Add
Q1 2026 5.21K $534.38K Reduce
Q2 2026 48.47K $4.40M Add
Q3 2026 47.81K $4.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Hamilton Capital, LLC held ABT?

Hamilton Capital, LLC has disclosed ABT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Hamilton Capital, LLC's current position in ABT?

As of Q3 2026, Hamilton Capital, LLC holds 47.81K shares of ABT (ABBOTT LABORATORIES), valued at $4.72M, representing 0.27% of its reported portfolio and ranking #20.

Has Hamilton Capital, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Hamilton Capital, LLC reduced its position in ABT. The position peaked in Q3 2026 at 47.81K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.